| Literature DB >> 22454257 |
Hee-Kyung Na1, Mi-Hee Kim, Kihyun Park, Soo-Ryoon Ryoo, Kyung Eun Lee, Hyesung Jeon, Ryong Ryoo, Changbong Hyeon, Dal-Hee Min.
Abstract
Among various nanoparticles, mesoporous silica nanoparticles (MSNs) have attracted extensive attention for developing efficient drug-delivery systems, mostly due to their high porosity and biocompatibility. However, due to the small pore size, generally below 5 nm in diameter, potential drugs that are loaded into the pore have been limited to small molecules. Herein, a small interfering RNA (siRNA) delivery strategy based on MSNs possessing pores with an average diameter of 23 nm is presented. The siRNA is regarded as a powerful gene therapeutic agent for treatment of a wide range of diseases by enabling post-transcriptional gene silencing, so-called RNA interference. Highly efficient, sequence-specific, and technically very simple target gene knockdown is demonstrated using MSNs with ultralarge pores of size 23 nm in vitro and in vivo without notable cytotoxicity.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22454257 DOI: 10.1002/smll.201200028
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 13.281